Q Therapeutics, Inc. Proceeds from Grantors
Q Therapeutics, Inc. reported Proceeds from Grantors of $677.86 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-07-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromGrantors · last filed 2014-07-31
- Q Therapeutics, Inc. proceeds from grantors for the quarter ending 2014-06-30 was $46.48K.
- Q Therapeutics, Inc. proceeds from grantors for the quarter ending 2014-03-31 was $631.38K, a 0.00% change year-over-year.
- Q Therapeutics, Inc. proceeds from grantors for the quarter ending 2013-12-31 was $0.00.
- Q Therapeutics, Inc. proceeds from grantors for the quarter ending 2013-09-30 was $0.00.
- Q Therapeutics, Inc. proceeds from grantors for fiscal 2013 was $631.38K, a 0.00% change from fiscal 2012.
- Q Therapeutics, Inc. proceeds from grantors for fiscal 2012 was $631.38K.
| Period end | Proceeds from Grantors 3 month | Proceeds from Grantors 6 month | Proceeds from Grantors 9 month | Proceeds from Grantors 12 month |
|---|---|---|---|---|
| 2014-06-30 | $46.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $677.86K 10-Q · filed 2014-07-31 | $677.86K derived: sum of 3 quarters · filed 2014-07-31 | $677.86K derived: sum of 4 quarters · filed 2014-07-31 |
| 2014-03-31 | $631.38K 10-Q · filed 2014-05-15 | $631.38K derived: sum of 2 quarters · filed 2014-05-15 | $631.38K derived: sum of 3 quarters · filed 2014-05-15 | $631.38K derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15 | $0.00 derived: sum of 2 quarters · filed 2014-04-15 | $0.00 derived: sum of 3 quarters · filed 2014-04-15 | $631.38K 10-K · filed 2014-04-15 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $631.38K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $631.38K 10-Q · filed 2013-08-13 | ||
| 2013-03-31 | $631.38K 10-Q · filed 2013-05-03 | |||
| 2012-12-31 | $631.38K 10-K · filed 2013-03-28 |